Real world outcomes of the new Tecnis Eyhance IOL.

Autor:	Gigon E; Department of Clinical Neurosciences, Division of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland., Bouthour W; Department of Clinical Neurosciences, Division of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland., Panos GD; Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK., Pajic B; Department of Clinical Neurosciences, Division of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland.; Eye Clinic Orasis, Swiss Eye Research Foundation, Reinach AG, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Faculty of Sciences, Department of Physics, University of Novi Sad, Novi Sad, Serbia.; Faculty of Medicine of the Military Medical Academy, University of Defense, Belgrade, Serbia., Massa H; Department of Clinical Neurosciences, Division of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland.
Jazyk:	angličtina
Zdroj:	European journal of ophthalmology [Eur J Ophthalmol] 2023 May; Vol. 33 (3), pp. 1390-1397. Date of Electronic Publication: 2022 Dec 25.
DOI:	10.1177/11206721221146675
Abstrakt:	Purpose: To compare the performance of Tecnis Eyhance ICB00 with Tecnis PCB00 IOL for far, intermediate, and near vision, in patients after bilateral cataract surgery. Settings: This study was done at Geneva University Hospitals. Design: This is a retrospective study of 224 eyes that underwent cataract between May 2019 and June 2020. Methods: Visual acuity was assessed from month 1 to 12 after surgery for distance, intermediate and near visual acuity, by the same optometrist, which was blind regarding the type of IOL. The patients answered to a quality of life questionnaire. Patients were excluded for: monocular surgery, macular disease, other IOL type, or inability to reach 20/20 visual acuity in both eyes without correction. Results: One hundred and fifty-two eyes were excluded. Three groups were then analyzed: PCB00 group (38 eyes), ICB00 group (22 eyes), and mismatch group (12 eyes). Monocular visual acuities (CIVA, UNVA and CNVA, in logMAR) were higher in the ICB00 group than the PCB00 group (respectively 0.3 vs 0.4, p = 0.0033; 0.3 vs 0.4, p = 0.0408; 0.3 vs 0.4, p = 0.0039). Binocular visual acuities, CIVA and CNVA were higher in the ICB00 group than the PCB00 group (0.2 vs 0.4, p = 0.0061; 0.15 vs 0.3, p = 0.018). This mirrored the findings of the quality of life questionnaire. There was no significant difference between PCB00 and mismatch groups. Conclusions: the Tecnis Eyhance was more effective for intermediate and near vision. The central defocus of the lens might help patients achieve spectacle independence and better quality of life.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu